Creative Planning’s Amphastar Pharmaceuticals AMPH Stock Holding History

Creative Planning’s Portfolio AMPH Stock Details AMPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.04M	Buy	51,444 +35,041	+214%	+$707K	﹤0.01%	2607
2026 Q1	$321K	Sell	16,403 -35,261	-68%	-$863K	﹤0.01%	3372
2025 Q4	$1.38M	Sell	51,664 -3,451	-6%	-$88.9K	﹤0.01%	2021
2025 Q3	$1.47M	Buy	55,115 +12,495	+29%	+$323K	﹤0.01%	1782
2025 Q2	$979K	Buy	42,620 +22,493	+112%	+$558K	﹤0.01%	1862
2025 Q1	$583K	Buy	20,127 +20,114	+154,723%	+$642K	﹤0.01%	2145
2024 Q4	$483	Buy	+13	New	+$594	﹤0.01%	3565
2018 Q3	–	Sell	-80,948	Closed	-$1.24M	–	2076
2018 Q2	$1.24M	Hold	80,948	–	–	﹤0.01%	636
2018 Q1	$1.52M	Sell	80,948 -12,000	-13%	-$226K	0.01%	542
2017 Q4	$1.79M	Sell	92,948 -1,000	-1%	-$18.7K	0.01%	493
2017 Q3	$1.68M	Hold	93,948	–	–	0.01%	518
2017 Q2	$1.68M	Sell	93,948 -2,000	-2%	-$31.7K	0.01%	492
2017 Q1	$1.39M	Hold	95,948	–	–	0.01%	551
2016 Q4	$1.77M	Sell	95,948 -206	-0.2%	-$4.01K	0.01%	439
2016 Q3	$1.82M	Buy	96,154 +70,206	+271%	+$1.27M	0.01%	399
2016 Q2	$418K	Hold	25,948	–	–	﹤0.01%	863
2016 Q1	$311K	Buy	+25,948	New	+$306K	﹤0.01%	975

Other funds holding AMPH

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Creative Planning's AMPH Position: Q2 2026 in Review

Creative Planning increased its Amphastar Pharmaceuticals (AMPH) stake by 214% in Q2 2026, buying an estimated $707K and bringing the position to 51,444 shares worth $1.04M. The position accounts for ﹤0.01% of the portfolio, ranked #2607.

Creative Planning first reported a position in AMPH in Q1 2016 and has held it in 17 quarters since. The position peaked at $1.82M in Q3 2016. 212 funds tracked by Wall St. Rank hold AMPH as of Q2 2026.

Creative Planning held 51,444 shares of Amphastar Pharmaceuticals worth $1.04M as of Q2 2026.
Creative Planning bought 35,041 Amphastar Pharmaceuticals shares in Q2 2026, an estimated $707K.
Amphastar Pharmaceuticals made up ﹤0.01% of Creative Planning's portfolio in Q2 2026, its #2607 holding.
Creative Planning first reported a position in Amphastar Pharmaceuticals in Q1 2016 and has held it in 17 quarters since.
Creative Planning's Amphastar Pharmaceuticals position peaked at $1.82M in Q3 2016.
212 funds tracked by Wall St. Rank held Amphastar Pharmaceuticals as of Q2 2026.

Based on Creative Planning's 13F filing for Q2 2026, filed 13 Aug 2026.